Valuation: Kamada Ltd.

Market Cap 1.25B 0 408M 358M 333M 306M 575M 39.08B 583M 3.96B 1.55B 19.3B 1.53B 1.5B 66.7B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 1.25B 0 408M 358M 333M 306M 575M 39.08B 583M 3.96B 1.55B 19.3B 1.53B 1.5B 66.7B EV / Sales 2026 *
2.08x
EV / Sales 2027 * 1.9x
Free-Float
54.51%
Yield 2026 *
-
Yield 2027 * -
1 day-1.90%
1 week-3.29%
Current month-3.06%
1 month-2.57%
3 months-13.58%
6 months-21.84%
Current year-6.24%
1 week 2,119
Extreme 2119
2,230
1 month 2,076
Extreme 2076
2,297
Current year 2,076
Extreme 2076
2,890
1 year 1,956
Extreme 1956
2,890
3 years 1,685
Extreme 1685
3,045
5 years 1,309
Extreme 1309
3,045
10 years 1,309
Extreme 1309
4,500
Manager TitleAgeSince
Chief Executive Officer 57 01/07/2015
Director of Finance/CFO 55 31/12/2017
Chief Operating Officer 53 01/11/2016
Director TitleAgeSince
Director/Board Member 64 24/12/2019
Chairman 77 07/03/2013
Director/Board Member 75 13/12/1990
Date Insider Type Main position Quantity % Market Cap.
7/4/26 Free

Director

32,000 0.0555%
7/4/26 Free

Chief Executive Officer

1,600,000 2.7738%
7/4/26 Free

Chief Financial Officer

405,000 0.7021%
Change 5-day change 1-year change 3-year change Capi.($)
-1.90%-3.29%-19.15%+14.48% 409M
+1.70%-0.74%+19.43%-10.41% 66.74B
-0.08%+2.72%+37.97%+204.36% 53.32B
+1.78%+54.50%+54.50%+54.50% 48.12B
+1.90%-5.62%-56.56%-55.72% 38.25B
-1.01%+0.10%+54.81%-23.84% 29.85B
+1.02%+2.78%+69.43%+89.65% 23.51B
+2.89%-6.49%+64.05%-53.06% 21.45B
+0.12%+4.16%+81.96%+161.81% 16.47B
+1.44%+0.48%+65.12%+127.90% 16.38B
Average +0.79%-0.73%+37.16%+50.97% 31.45B
Weighted average by Cap. +1.11%-0.31%+34.44%+49.97%

Financials

2026 *2027 *
Net sales 600M 0 196M 173M 161M 148M 277M 18.83B 281M 1.91B 746M 9.3B 737M 721M 32.13B 655M 0 214M 188M 175M 161M 302M 20.53B 306M 2.08B 813M 10.14B 804M 786M 35.04B
Net income 73.89M 0 24.17M 21.25M 19.78M 18.16M 34.1M 2.32B 34.55M 235M 91.81M 1.14B 90.72M 88.77M 3.96B 105M 0 34.48M 30.31M 28.22M 25.91M 48.66M 3.31B 49.3M 335M 131M 1.63B 129M 127M 5.64B
Net Debt - -
Logo Kamada Ltd.
Kamada Ltd is Israel based company, focused on plasma-derived protein therapeutics with a commercial product portfolio and a late-stage product pipeline. The Company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.
Employees
462
Date Price Change Volume
28/07/26 ILA 2,119.00 -1.90% 64,766
24/07/26 ILA 2,160.00 -0.60% 30,768
22/07/26 ILA 2,173.00 -1.27% 78,689
21/07/26 ILA 2,201.00 +0.46% 43,808
20/07/26 ILA 2,191.00 +2.77% 422,843
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. KMDA Stock